Simcere Pharmaceutical Group (NYSE: SCR) today reported that China's State Food and Drug Administration has initiated a comprehensive ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE